Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program
about
Are the Conventional Commercial Yeast Identification Methods Still Helpful in the Era of New Clinical Microbiology Diagnostics? A Meta-Analysis of Their AccuracyCandida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005Disruption of Protein Mannosylation Affects Candida guilliermondii Cell Wall, Immune Sensing, and VirulenceEpidemiology of invasive candidiasis: a persistent public health problemEpidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008.Molecular evidence on the occurrence of co-infection with Pichia guilliermondii and Wuchereria bancrofti in two filarial endemic districts of IndiaMolecular epidemiology and azole resistance mechanism study of Candida guilliermondii from a Chinese surveillance system.Are subinhibitory concentrations of antibiotics the only culprit of antibiotic resistance?Comparison of human and soil Candida tropicalis isolates with reduced susceptibility to fluconazoleDevelopment of two molecular approaches for differentiation of clinically relevant yeast species closely related to Candida guilliermondii and Candida famata.Echinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden.Assessment of epiphytic yeast diversity in rice (Oryza sativa) phyllosphere in Thailand by a culture-independent approach.Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testIn situ photoimmunotherapy for cutaneous granuloma caused by itraconazole-resistant Candida guilliermondii.Debaryomyces hansenii (Candida famata), a rare human fungal pathogen often misidentified as Pichia guilliermondii (Candida guilliermondii)Exploring ecological modelling to investigate factors governing the colonization success in nosocomial environment of Candida albicans and other pathogenic yeasts.Identification and Antifungal Susceptibility Profile of Candida guilliermondii and Candida fermentati from a Multicenter Study in China.Comparative evolution of morphological regulatory functions in Candida species.What do we know about Candida guilliermondii? A voyage throughout past and current literature about this emerging yeast.Candida guilliermondii: biotechnological applications, perspectives for biological control, emerging clinical importance and recent advances in genetics.Species distribution and susceptibility profile of Candida species in a Brazilian public tertiary hospital.Candida fermentati as a cause of persistent fungemia in a preterm neonate successfully treated by combination therapy with amphotericin B and caspofungin.Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.A chronic hemodialysis patient with isolated pulmonary valve infective endocarditis caused by non-albicans Candida: a rare case and literature review.Candida guilliermondii Complex Is Characterized by High Antifungal Resistance but Low Mortality in 22 Cases of Candidemia.Investigation of a Candida guilliermondii Pseudo-outbreak Reveals a Novel Source of Laboratory Contamination.Breakthrough fungemia due to Candida fermentati with fks1p mutation under micafungin treatment in a cord blood transplant recipient.Uncommon Candida Species Fungemia among Cancer Patients, Houston, Texas, USA.Update on Antifungal Drug Resistance.Clinical and microbiological investigation of fungemia from four hospitals in China.In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.Elevated chitin content reduces the susceptibility of Candida species to caspofungin.Identification and Susceptibility Profile of Candida fermentati from a worldwide collection of Candida guilliermondii clinical isolates.Identifying the emerging human pathogen Scedosporium prolificans by using a species-specific monoclonal antibody that binds to the melanin biosynthetic enzyme tetrahydroxynaphthalene reductase.Molecular Confirmation of the Relationship between Candida guilliermondii Fks1p Naturally Occurring Amino Acid Substitutions and Its Intrinsic Reduced Echinocandin Susceptibility.Recent experience with fungaemia: change in species distribution and azole resistance.Internal transcribed spacer region sequence analysis using SmartGene IDNS software for the identification of unusual clinical yeast isolates.The Genomes of Four Meyerozymacaribbica Isolates and Novel Insights into the Meyerozymaguilliermondii Species Complex.A TRP5/5-fluoroanthranilic acid counter-selection system for gene disruption in Candida guilliermondii.
P2860
Q28084765-44DFEA34-7916-4292-81FF-826DB59FCA8BQ28260910-9664DC1C-CEF6-4F7F-883F-75E5F36690F2Q28818151-3B2BA722-0474-4A7F-B79E-ABFA7CAC3B1CQ29616758-5AB66E06-F71B-4F46-86A3-AEF65E316E00Q30834974-12FB740B-148B-463D-A05D-C8F8DA18F597Q33615436-F1AC0E95-B50D-49DC-89BD-CEE6B915FB8CQ33680814-B14D431B-0743-4F99-B70F-5F57D4FD16ABQ34084784-E1E9D7AF-56BD-437D-99AE-2379730CFCB9Q34230214-CB6873E4-D939-4228-BF51-3048DF7CD028Q35035707-2DD122BB-3190-4B6F-A090-CF2F0BC7D6CCQ35140020-5F09586C-602A-4B24-975C-E251B0BF580CQ35595190-C8AB488B-95D2-4ECB-9784-4C1FC60F7005Q35913918-2E5B8BE3-EBCC-4245-B3EC-C4600EC4EFABQ36058170-2A6514D4-A92C-4001-92F8-95DD980F1A9DQ36933554-5D838B8C-4F9C-4A37-9742-335C8CCA1D59Q36953947-570CD22D-B7B1-4DA1-979E-CC53266D812DQ37132105-41D29619-5714-43B2-A4E1-0B89F60EEC3DQ37263608-BF25D5D2-9796-4A8A-9961-263418163D09Q37805648-1877BD36-1C59-4F2F-BE87-EEC7259A6740Q38490686-6CFFEF00-A103-4EB3-8609-9E82EBFE1FDEQ39361000-16653966-E85E-4E7D-B4AB-6D304361808FQ39420285-6CD150FA-F489-480E-86F0-DE3BF796AAC0Q39899742-69245722-2E70-4591-A232-4BF9FA69D63BQ40066198-680F3CC3-9197-4445-8E8B-5FC6E7DBB02DQ40239343-978FB309-B13C-4BE2-89F8-524E21C733E9Q40366541-73A6ED69-9F8A-439F-95D3-61E317AB70AFQ40446419-9BEF4AA4-C53A-4E9D-B823-A18D33F3795AQ40942390-3CA8697C-97BF-4193-8213-04DC30545ADEQ41135029-00A3613A-BE50-49F3-9303-096049BA9408Q41462402-CD7E974A-B3D6-4949-91C7-21BF667FD0A9Q41810114-9B16C2C1-836B-4AD8-AA44-7393D557AB5EQ41833155-0FF0555F-C989-4757-BBEB-7573BB919DA4Q41843284-23A00A06-2A61-43F2-9422-E0B91666A893Q42137437-289132DC-4C68-46B2-A53B-00DA7E1ED2F9Q42221359-C59BE66E-E792-444C-96C7-646B66857C2DQ42358865-E489F2F7-53F5-4649-81D4-0CB8FD9235F9Q44253835-272850CF-F75A-4863-B9BA-E2367E6B5782Q48054383-1DACCFD9-E249-42FF-9799-1A7445F1C892Q50134029-C19C82B0-A1B1-4B79-9EDC-02625FED7322Q52625634-D20D60CE-9764-4EA4-9437-F14D10361AE4
P2860
Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Candida guilliermondii, an opp ...... ntifungal surveillance program
@ast
Candida guilliermondii, an opp ...... ntifungal surveillance program
@en
type
label
Candida guilliermondii, an opp ...... ntifungal surveillance program
@ast
Candida guilliermondii, an opp ...... ntifungal surveillance program
@en
prefLabel
Candida guilliermondii, an opp ...... ntifungal surveillance program
@ast
Candida guilliermondii, an opp ...... ntifungal surveillance program
@en
P2093
P2860
P356
P1476
Candida guilliermondii, an opp ...... ntifungal surveillance program
@en
P2093
P2860
P304
P356
10.1128/JCM.00865-06
P407
P577
2006-10-01T00:00:00Z